Vraylar sales in U.S. boost Richter Q2 result

Revenue rose 8.5% to HUF 120 billion.

Richter expected to post higher revenue, lower profit in Q2

Analysts forecast 30% lower net profit.

Drug makers could pay Hungary central budget HUF 100 bn in 2020

Hungary's Richter inks exclusive license deal for Australia, New Zealand

Richter to supply, Seqirus to sell.

Hungary Richter profit leaps in the first quarter of 2019

Revenues and profit overshoot estimates.

Hungary's Richter to report impressive profit growth for Q1

Earnings report to be released on 10 May.

Hungary's Richter buys minority stake in U.S. company

Via convertible notes.

Hungary Richter to pay HUF 100 dividend per share

From 2018 profits. Invitation for AGM shows.

Homeopathy is ineffective, pharmacies need to inform buyers in Hungary

Life is hard.

Hungary Richter quarterly profit plummets

One-off item dents profits.

Change in the executive management of Hungary's Richter

New technical director to be appointed.

Egis expands is plant in Körmend Hungary

With EUR 25 million investment.

Hungary Richter reports double-digit drop in Q3 after-tax profit

Drop in Esmya sales weigh on results.

Hungary's Richter receives good news

Pharmafarm is back in business.

Hungary's Richter to sell new drug in EU

Signs license and distribution agreement.

Hungary Richter adds new item to product line

Women's Healthcare portfolio expanded.

Hungary Richter seen reporting profit boom for Q2

There are some crucial questions, though.

Hungary Richter buys intellectual property rights

For drug launch in the United States.

Romanian wholesaler of Hungary's Richter suspended

Hungary's leading pharma company reacts.

ANALYST VIEW - Jefferies lowers target price for Hungary's Richter

To HUF 5,470 from HUF 5,695.